Measurement of the Association of Pain with Clinical Characteristics in Oral Cancer Patients at Diagnosis and Prior to Cancer Treatment

References

• Connelly ST, Schmidt BL. Evaluation of pain in patients with oral squamous cell carcinoma. J Pain. 2004;5(9):505–510. doi:10.1016/j.jpain.2004.09.002
   PubMed Web of Science ®Google Scholar
• Kolokythas A, Connelly ST, Schmidt BL. Validation of the University of California San Francisco oral cancer pain questionnaire. J Pain. 2007;8(12):950–953. doi:10.1016/j.jpain.2007.06.012
   PubMed Web of Science ®Google Scholar
• Borggreven PA, Verdonck-de Leeuw IM, Muller MJ, et al. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol. 2007;264(6):651–657. doi:10.1007/s00405-007-0249-5
   PubMed Web of Science ®Google Scholar
• Hammerlid E, Bjordal K, Ahlner-Elmqvist M, et al. A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope. 2001;111(4 Pt 1):669–680. doi:10.1097/00005537-200104000-00021
   PubMed Web of Science ®Google Scholar
• Oliveira KG, von Zeidler SV, Podesta JR, et al. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy. BMC Cancer.2014;14(1):39. doi: 10.1186/1471-2407-14-39.
   PubMedGoogle Scholar
• Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival Research Support. Extramural J Pain. 2014;15(10):1015–1022. doi:10.1016/j.jpain.2014.07.003
   PubMed Web of Science ®Google Scholar
• Hussein AA, Helder MN, de Visscher JG, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer. 2017;82:115–127. doi:10.1016/j.ejca.2017.05.026
   PubMed Web of Science ®Google Scholar
• Tota JE, Anderson WF, Coffey C, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol Apr. 2017;67:146–152. doi:10.1016/j.oraloncology.2017.02.019
   PubMed Web of Science ®Google Scholar
• Parikh AS, Puram SV, Faquin WC, et al. Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis. Oral Oncol. 2019;99:104458. doi:10.1016/j.oraloncology.2019.104458
   PubMed Web of Science ®Google Scholar
• Puram SV, Tirosh I, Parikh AS, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017;171(7):1611–1624 e24. doi: 10.1016/j.cell.2017.10.044.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Janal MN, Veeramachaneni R, et al. Oncogenes overexpressed in metastatic oral cancers from patients with pain: potential pain mediators released in exosomes. Sci Rep. 2020;10(1):14724. doi: 10.1038/s41598-020-71298-y.
   PubMed Web of Science ®Google Scholar
• Oliveira KG, von Zeidler SV, Lamas AZ, et al. Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy. Braz J Med Biol Res. 2014;47(7):600–604. doi:10.1590/1414-431x20143599
   PubMed Web of Science ®Google Scholar
• Holen JC, Lydersen S, Klepstad P, Loge JH, Kaasa S. The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain. 2008;24(3):219–225. doi:10.1097/AJP.0b013e31815ec22a
   PubMed Web of Science ®Google Scholar
• Scheff NN, Bhattacharya A, Dowse E, et al. Neutrophil-Mediated Endogenous Analgesia Contributes to Sex Differences in Oral Cancer Pain. Front Integr Neurosci. 2018;12:52. doi:10.3389/fnint.2018.00052
   PubMed Web of Science ®Google Scholar
• Salvo E, Campana WM, Scheff NN, et al. Peripheral nerve injury and sensitization underlie pain associated with oral cancer perineural invasion. Pain. 2020;161(11):2592–2602. doi:10.1097/j.pain.0000000000001986
   PubMed Web of Science ®Google Scholar
• Naik K, Janal MN, Chen J, et al. The Histopathology of Oral Cancer Pain in a Mouse Model and a Human Cohort. J Dent Res. 2021;100(2):194–200. doi:10.1177/0022034520961020
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129–138.
   PubMedGoogle Scholar
• Klepstad P, Borchgrevink PC, Dale O, et al. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med. 2003;17(8):679–687. doi:10.1191/0269216303pm835oa
   PubMed Web of Science ®Google Scholar
• Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015. doi: 10.1093/nar/gkv468. 43(W1):W566–70
   Web of Science ®Google Scholar
• Schmitd LB, Beesley LJ, Russo N, et al. Redefining Perineural Invasion: integration of Biology With Clinical Outcome. Neoplasia. 2018;20(7):657–667. doi:10.1016/j.neo.2018.04.005
   PubMed Web of Science ®Google Scholar
• Wilkie DJ, Huang HY, Reilly N, Cain KC. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage. 2001;22(5):899–910. doi:10.1016/s0885-3924(01)00351-7
   PubMed Web of Science ®Google Scholar
• Lam DK, Schmidt BL. Orofacial pain onset predicts transition to head and neck cancer. Pain. 2011;152(5):1206–1209. doi:10.1016/j.pain.2011.02.009
   PubMed Web of Science ®Google Scholar
• Viet CT, Schmidt BL. Biologic mechanisms of oral cancer pain and implications for clinical therapy. J Dent Res. 2012;91(5):447–453. doi:10.1177/0022034511424156
   PubMed Web of Science ®Google Scholar
• Dubeykovskaya ZA, Tu NH, Garcia PDR, Schmidt BL, Albertson DG. Oral Cancer Cells Release Vesicles that Cause Pain. Adv Biol (Weinh). 2022;6(9):e2200073. doi:10.1002/adbi.202200073
   PubMedGoogle Scholar
• de Almeida AS, Bernardes LB, Trevisan G. TRP channels in cancer pain. Eur J Pharmacol. 2021. 904;174185. doi:10.1016/j.ejphar.2021.174185
   PubMed Web of Science ®Google Scholar
• Ruparel S, Bendele M, Wallace A, Green D. Released lipids regulate transient receptor potential channel (TRP)-dependent oral cancer pain. Mol Pain. 2015. 11;30. doi:10.1186/s12990-015-0016-3
   PubMed Web of Science ®Google Scholar
• Ye Y, Ono K, Bernabe DG, et al. Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers. Acta Neuropathol Commun. 2014;2(1):62. doi: 10.1186/2051-5960-2-62.
   PubMedGoogle Scholar
• Ye Y, Dang D, Zhang J, et al. Nerve growth factor links oral cancer progression, pain, and cachexia. Research Support, N I H, Extramural Mol Cancer Ther. 2011;10(9):1667–1676. doi:10.1158/1535-7163.MCT-11-0123
   PubMed Web of Science ®Google Scholar
• Lam DK, Dang D, Flynn AN, Hardt M, Schmidt BL. TMPRSS2, a novel membrane-anchored mediator in cancer pain. Pain. 2015;156(5):923–930. doi:10.1097/j.pain.0000000000000130
   PubMed Web of Science ®Google Scholar
• Lam DK, Dang D, Zhang J, Dolan JC, Schmidt BL. Novel animal models of acute and chronic cancer pain: a pivotal role for PAR2. Research Support, N.I.H., Extramural. J Neurosci. 2012;32(41):14178–14183. doi:10.1523/JNEUROSCI.2399-12.2012
   PubMed Web of Science ®Google Scholar
• Lam DK, Schmidt BL. Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain. 2010;149(2):263–272. doi:10.1016/j.pain.2010.02.010
   PubMed Web of Science ®Google Scholar
• Tu NH, Inoue K, Chen E, et al. Cathepsin S Evokes PAR2-Dependent Pain in Oral Squamous Cell Carcinoma Patients and Preclinical Mouse Models. Cancers (Basel). 2021;13(18):4697. doi:10.3390/cancers13184697
   PubMed Web of Science ®Google Scholar
• Tu NH, Jensen DD, Anderson BM, et al. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2. J Neurosci. 2021;41(1):193–210. doi: 10.1523/JNEUROSCI.1211-20.2020.
   PubMed Web of Science ®Google Scholar
• Scheff NN, Ye Y, Bhattacharya A, et al. Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation. Pain. 2017;158(12):2396–2409. doi:10.1097/j.pain.0000000000001044
   PubMed Web of Science ®Google Scholar
• Andratsch M, Mair N, Constantin CE, et al. A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci. 2009;29(43):13473–13483. doi: 10.1523/JNEUROSCI.1822-09.2009.
   PubMed Web of Science ®Google Scholar
• Viet CT, Dang D, Ye Y, Ono K, Campbell RR, Schmidt BL. Demethylating drugs as novel analgesics for cancer pain. Clin Cancer Res. 2014;20(18):4882–4893. doi:10.1158/1078-0432.CCR-14-0901
   PubMed Web of Science ®Google Scholar
• Viet CT, Ye Y, Dang D, et al. Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain. Pain. 2011;152(10):2323–2332. doi:10.1016/j.pain.2011.06.025
   PubMed Web of Science ®Google Scholar
• Li X, Chen Y, Wang J, Jiang C, Huang Y. Lung Cancer Cell-Derived Exosomal let-7d-5p Down-Regulates OPRM1 to Promote Cancer-Induced Bone Pain. Front Cell Dev Biol. 2021;9:666857. doi:10.3389/fcell.2021.666857
   PubMed Web of Science ®Google Scholar
• Hoshikawa N, Sakai A, Takai S, Suzuki H. Targeting Extracellular miR-21-TLR7 Signaling Provides Long-Lasting Analgesia in Osteoarthritis. Mol Ther Nucleic Acids. 2020. 19;199–207. doi:10.1016/j.omtn.2019.11.011
   PubMedGoogle Scholar